跳至主要内容
临床试验/NCT02727491
NCT02727491已完成4 期

A Prospective Randomized Double-blind Placebo Controlled Trial; Does Pre and Postoperative Dextromethorphan Reduce Post-tonsillectomy Pain in Children?

Dr. Rachel Rooney0 个研究点目标入组 85 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
85
主要终点
integrated assessment of pain scores and opioid use

研究概览

简要总结

With Institutional ethics board and Health Canada approval, pediatric patients (ages 3-12) undergoing tonsillectomy or adenotonsillectomy (under standardized anesthesia) will be randomized to receive dextromethorphan hydrobromide (1mg/kg orally) 30 min preoperatively and again 8 hours postoperatively OR placebo (syrup identical in taste, appearance and volume) at the same time points. The primary outcome is an integrated assessment of perioperative pain scores and opioid use for 24 hours postoperatively. Secondary outcomes include nausea, vomiting, respiratory depression, and bleeding for 24 hours postoperatively. Our hypothesis is that dextromethorphan will decrease the incidence/severity of post-tonsillectomy pain. The improved pain control will be apparent through reduced opioid consumption and integrated pain scores. This will result in a reduced incidence of opioid-related side effects and adverse events.

详细描述

With Institutional ethics board and Health Canada approval and parental consent and child assent, pediatric patients (ages 3-12) undergoing tonsillectomy or adenotonsillectomy (under standardized anesthesia) will be randomized to receive dextromethorphan hydrobromide (1mg/kg orally) 30 min preoperatively and again 8 hours postoperatively OR placebo (syrup identical in taste, appearance and volume) at the same time points. The primary outcome is an integrated assessment of perioperative pain scores and opioid use for 24 hours postoperatively. Pain scores were collected preoperatively at rest and then at 1,2,3,8,9,10 and 24 hours postoperatively using the validated Children's Hospital of Eastern Ontario Pain Scale (CHEOPS). Secondary outcomes include nausea, vomiting, respiratory depression, and bleeding recorded by blinded observers for 24 hours postoperatively.

Our hypothesis is that dextromethorphan will decrease the incidence/severity of post-tonsillectomy pain. The improved pain control will be apparent through reduced opioid consumption and integrated pain scores. This will result in a reduced incidence of opioid-related side effects and adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologist's (ASA) physical classification I and II
  • tonsillectomy or adenotonsillectomy
  • admission to extended postoperative care unit

排除标准

  • use of monoamine oxidase inhibitors, serotonin reuptake inhibitors or tricyclic antidepressants
  • requirement of preoperative sedation
  • recent dextromethorphan use (<24 h before surgery)
  • intolerance, sensitivity or contraindication to any agents used in the study
  • pre-existing chronic pain or chronic analgesic use
  • body mass index (BMI) for age percentile greater than 90
  • confounding procedural factors which might affect the validity of the data
  • inability to adhere to study protocol
  • contraindication to volatile anesthetics

研究组 & 干预措施

dextromethorphan

Experimental

1 mg/kg of dextromethorphan syrup orally 30 min preoperatively and then again 8 hours post-tonsillectomy

干预措施: Dextromethorphan (Drug)

Placebo

Placebo Comparator

30 min preoperatively and then again 8 hours postoperatively, received inactive placebo syrup identical in volume, appearance and taste as the experimental group

干预措施: Placebo (Drug)

结局指标

主要结局

integrated assessment of pain scores and opioid use

时间窗: 24 hours postoperatively

The Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) will be measured at rest 24 hours postoperatively and this will be integrated with total opioid consumption at 24 hours postoperatively. This will be achieved by converting both pain scores and opioid consumption to % change. The % differences for each of the 2 variables are then added together on a per-subject basis to provide a summated % difference. The individual and summated % differences can then be plotted on a single graph and the integrated ranks of the experimental and control groups can be compared with standard statistical tests.(1)

次要结局

  • opioid-related adverse effects(up to 24 hours postoperatively)
  • pain scores(1,2,3,8,9 and 10 hours postoperatively)

研究者

发起方
Dr. Rachel Rooney
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Rachel Rooney

Dr. Rachel Rooney

Queen's University

相似试验